文献速递关节外科创伤骨科

全膝关节置换术后假体周围感染使用抗生素骨水泥占位器治疗时的急性肾损伤:发生率、风险与结局

Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers: Incidence, Risks, and Outcomes.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

本研究回顾性分析2000至2017年间424例因全膝关节置换术后假体周围感染行切除并置入455个高剂量抗生素骨水泥占位器的患者,发现无慢性肾病者急性肾损伤发生率为14%,而既往慢性肾病患者为45%(OR=5)。万古霉素或氨基糖苷类浓度每批次骨水泥>3.6 g时风险增加(OR分别为1.9和1.8),高血压、围手术期低血容量和急性房颤是无慢性肾病患者急性肾损伤的独立预测因素。

要点

  • 无慢性肾病患者急性肾损伤发生率为14%,既往慢性肾病患者为45%(OR=5;p=0.0001)。
  • 万古霉素或氨基糖苷类浓度每批次骨水泥>3.6 g时急性肾损伤风险增加(OR分别为1.9和1.8;p均=0.02)。
  • 高血压、围手术期低血容量和急性房颤是无慢性肾病患者急性肾损伤的独立预测因素。

核心结论

  • 在无基线肾功能损害的患者中,全膝关节置换术后假体周围感染行二期翻修术时急性肾损伤发生率为14%,其中2%进展为慢性肾病。
  • 既往存在慢性肾病的患者急性肾损伤风险是无慢性肾病患者的5倍。
  • 急性肾血流受损的原因(高血压、围手术期低血容量、急性房颤)是无慢性肾病患者发生急性肾损伤的独立预测因素。

研究设计与样本

  • 回顾性队列研究,纳入2000至2017年间424例因初次全膝关节置换术后假体周围感染行切除并置入455个抗生素骨水泥占位器的患者。
  • 患者平均年龄67岁,平均体重指数33 kg/m2,47%为女性,15%有既往慢性肾病。
  • 所有患者同时接受全身抗生素治疗平均6周,平均随访6年(范围2至17年)。
  • 急性肾损伤定义为48小时内肌酐≥基线1.5倍或升高≥0.3 mg/dL。

主要发现

  • 无一例需要急性透析。
  • 万古霉素浓度每批次骨水泥>3.6 g时急性肾损伤风险增加(OR=1.9;p=0.02),氨基糖苷类浓度每批次骨水泥>3.6 g时风险亦增加(OR=1.8;p=0.02)。
  • 无既往慢性肾病患者中,高血压(β=0.17;p=0.002)、围手术期低血容量(β=0.28;p=0.0001)和急性房颤(β=0.13;p=0.009)是急性肾损伤的独立预测因素。
  • 末次随访时,8例曾发生急性肾损伤的患者进展为慢性肾病,其中4例接受透析。

关键数值与推荐

  • 急性肾损伤定义:肌酐≥基线1.5倍或48小时内升高≥0.3 mg/dL。
  • 无慢性肾病患者急性肾损伤发生率14%,既往慢性肾病患者45%(OR=5;p=0.0001)。
  • 万古霉素或氨基糖苷类浓度每批次骨水泥>3.6 g时急性肾损伤风险增加(OR分别为1.9和1.8;p均=0.02)。
  • 证据等级:治疗性IV级。

临床怎么用

  • 对全膝关节置换术后假体周围感染行二期翻修术的患者,应评估基线肾功能,尤其关注既往慢性肾病患者。
  • 配制抗生素骨水泥占位器时,需注意万古霉素和氨基糖苷类浓度每批次骨水泥不宜超过3.6 g以降低急性肾损伤风险。
  • 围手术期应管理高血压、维持血容量、监测并处理急性房颤,以降低无慢性肾病患者急性肾损伤风险。

局限性

  • 本研究为回顾性设计,证据等级为治疗性IV级。
  • 原文未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Two-stage exchange arthroplasty with a high-dose antibiotic-loaded bone cement (ALBC) spacer and intravenous or oral antibiotics is the most common method of managing a periprosthetic joint infection (PJI) after a total knee arthroplasty (TKA). However, little is known about the contemporary incidence, the risk factors, and the outcomes of acute kidney injuries (AKIs) in this cohort. METHODS: We identified 424 patients who had been treated with 455 ALBC spacers after resection of a PJI following a primary TKA from 2000 to 2017. The mean age at resection was 67 years, the mean body mass index (BMI) was 33 kg/m2, 47% of the patients were women, and 15% had preexisting chronic kidney disease (CKD). The spacers (87% nonarticulating) contained a mean of 8 g of vancomycin and 9 g of an aminoglycoside per construct (in situ for a mean of 11 weeks). Eighty-six spacers also had amphotericin B (mean, 412 mg). All of the patients were concomitantly treated with systemic antibiotics for a mean of 6 weeks. An AKI was defined as a creatinine level of ≥1.5 times the baseline or an increase of ≥0.3 mg/dL within any 48-hour period. The mean follow-up was 6 years (range, 2 to 17 years). RESULTS: Fifty-four AKIs occurred in 52 (14%) of the 359 patients without preexisting CKD versus 32 AKIs in 29 (45%) of the 65 patients with CKD (odds ratio [OR], 5; p = 0.0001); none required acute dialysis. Overall, when the vancomycin concentration or aminoglycoside concentration was >3.6 g/batch of cement, the risk of AKI increased (OR, 1.9 and 1.8, respectively; p = 0.02 for both). Hypertension (β = 0.17; p = 0.002), perioperative hypovolemia (β = 0.28; p = 0.0001), and acute atrial fibrillation (β = 0.13; p = 0.009) were independent predictors for AKI in patients without preexisting CKD. At the last follow-up, 8 patients who had sustained an AKI had progressed to CKD, 4 of whom received dialysis. CONCLUSIONS: In our study, the largest series to date that we are aware of regarding this issue, AKI occurred in 14% of patients with normal renal function at baseline, and 2% developed CKD after undergoing a 2-stage exchange arthroplasty for a PJI after TKA. However, the risk of AKI was fivefold greater in those with preexisting CKD. The causes of acute renal blood flow impairment were independent predictors for AKI. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Dagneaux L, Limberg AK, Osmon DR, et al. Acute Kidney Injury When Treating Periprosthetic Joint Infections After Total Knee Arthroplasties with Antibiotic-Loaded Spacers: Incidence, Risks, and Outcomes. J Bone Joint Surg Am. 2021. PMID: 33780403. doi:10.2106/JBJS.20.01825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。